The Pennant Group, Inc. (PNTG)
NASDAQ: PNTG · Real-Time Price · USD
27.61
-0.48 (-1.71%)
Nov 28, 2025, 1:00 PM EST - Market closed
The Pennant Group Revenue
The Pennant Group had revenue of $229.04M in the quarter ending September 30, 2025, with 26.76% growth. This brings the company's revenue in the last twelve months to $847.27M, up 29.89% year-over-year. In the year 2024, The Pennant Group had annual revenue of $695.24M with 27.59% growth.
Revenue (ttm)
$847.27M
Revenue Growth
+29.89%
P/S Ratio
1.13
Revenue / Employee
$121,039
Employees
7,000
Market Cap
958.25M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 695.24M | 150.35M | 27.59% |
| Dec 31, 2023 | 544.89M | 71.65M | 15.14% |
| Dec 31, 2022 | 473.24M | 33.55M | 7.63% |
| Dec 31, 2021 | 439.69M | 48.74M | 12.47% |
| Dec 31, 2020 | 390.95M | 52.42M | 15.49% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
PNTG News
- 22 days ago - The Pennant Group, Inc. (PNTG) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 24 days ago - The Pennant Group Announces Expansion of Credit Facility - GlobeNewsWire
- 24 days ago - Pennant Acquires Senior Living Communities in Idaho and Wisconsin - GlobeNewsWire
- 25 days ago - Wasatch Micro Cap Fund Q3 2025 Performance Update - Seeking Alpha
- 5 weeks ago - Pennant Announces Third Quarter 2025 Earnings Release and Call - GlobeNewsWire
- 2 months ago - UPDATE — Pennant Completes Purchase of Tennessee, Georgia and Alabama Operations from UnitedHealth Group and Amedisys - GlobeNewsWire
- 2 months ago - Pennant Completes Purchase of Tennessee, Georgia and Alabama Operations from UnitedHealth Group and Amedisys - GlobeNewsWire
- 2 months ago - Generational Group Advises Healing Hearts Home Health in Its Sale to the Pennant Group, Inc. - Business Wire